Project FARA Award – Speech treatment in Friedreich ataxia

Basic data

Acronym:
FARA Award
Title:
Speech treatment in Friedreich ataxia
Duration:
16/11/2017 to 15/11/2020
Abstract / short description:
Disordered speech is a devastating and inevitable consequence of many hereditary ataxias, particularly in Friedreich ataxia (FRDA).Here we test the effectiveness of a home-based, intensive four-week speech exercise program designed to improve speech in people with FRDA, aiming to establish the world-first evidence-based speech therapy for FRDA. Specifically, our aim is to evaluate the hypothesis that intensive speech rehabilitation using biofeedback will lead to improved speech intelligibility (i.e., ability to be understood) in FRDA compared to existing care. If this hypothesis is supported, our research will change the landscape of clinical care for FRDA globally by influencing health policy and improving patient outcomes in this disease group and likely also other degenerative ataxias.
Keywords:
therapies
Therapien
FARA award
Speech treatment
Friedreich Ataxia
Hereditary Ataxia

Involved staff

Managers

Faculty of Medicine
University of Tübingen
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Neurology with Focus on Neurodegenerative Disorders
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine
Help

will be deleted permanently. This cannot be undone.